Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
SHANGHAI PECHEM
00338
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -19.88%60.49B | -23.73%67.24B | -17.64%65.68B | -19.91%74B | -9.11%75.5B | -11.67%88.16B | -23.08%79.75B | -24.38%92.4B | -40.67%83.07B | -27.25%99.81B |
| Transactional financial assets | 297.06%67.09M | -61.52%68.02M | 21.57%16.99M | 0.39%13.86M | 22.38%16.9M | 1,198.27%176.75M | -4.75%13.97M | -5.31%13.81M | -5.49%13.81M | -24.96%13.61M |
| Notes receivable and accounts receivable | 15.54%10.65B | 17.12%9.52B | -2.25%9.6B | -2.52%9.34B | 4.73%9.22B | 11.35%8.13B | 4.63%9.82B | 5.14%9.58B | 2.30%8.8B | -2.80%7.3B |
| -Notes receivable | -79.49%6.28M | -87.43%2.37M | -20.62%8.55M | -13.29%27.96M | 24.61%30.62M | 147.45%18.86M | 7.31%10.77M | 153.79%32.25M | 490.75%24.57M | 16.31%7.62M |
| -Accounts receivable | 15.86%10.64B | 17.36%9.52B | -2.23%9.59B | -2.49%9.31B | 4.67%9.19B | 11.20%8.11B | 4.63%9.81B | 4.93%9.55B | 2.06%8.78B | -2.81%7.29B |
| Other receivables (including interest and dividends) | -21.09%172.3B | -20.78%175.41B | -18.79%208.96B | -17.88%215.55B | -15.61%218.35B | -13.11%221.43B | -4.42%257.31B | -0.12%262.48B | -7.69%258.75B | -6.55%254.84B |
| -Dividend receivable | -95.99%2.59M | -71.48%18.58M | -51.67%27.97M | --288.94M | -12.77%64.6M | --65.14M | --57.88M | ---- | 23.40%74.05M | ---- |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | -99.72%523.37K | --523.37K | --10.25M | ---- | 148.89%185.96M | ---- |
| -Other receivable | ---- | ---- | ---- | --215.26B | -15.55%218.29B | --221.36B | --257.24B | ---- | -7.74%258.49B | ---- |
| Contractual assets | -11.28%11.37B | -6.74%11.94B | -8.91%12.46B | -11.66%12.34B | -3.61%12.81B | -6.41%12.8B | 5.11%13.68B | 14.27%13.97B | 15.87%13.29B | 25.17%13.68B |
| Advance payment | -66.99%18.03B | -3.42%18.1B | -16.60%51.41B | -17.86%52.47B | -7.19%54.63B | -66.97%18.74B | 2.06%61.65B | 2.85%63.87B | -5.69%58.86B | -6.18%56.74B |
| Inventories | -26.77%365.66B | -27.99%373.74B | -26.97%423.08B | -25.45%462.52B | -25.70%499.31B | -26.03%519.01B | -28.89%579.34B | -25.88%620.4B | -23.43%672.06B | -22.64%701.7B |
| Other current assets | 202.14%40.78B | -15.72%41.35B | -19.96%11.79B | -18.04%12.7B | -16.84%13.5B | 207.10%49.06B | -21.56%14.73B | -19.70%15.5B | -20.81%16.23B | -17.70%15.98B |
| Total current assets | -23.09%679.34B | -23.99%697.37B | -22.96%782.99B | -22.19%838.93B | -20.50%883.33B | -20.23%917.51B | -21.19%1.02T | -18.63%1.08T | -20.70%1.11T | -18.73%1.15T |
| Non Current assets | ||||||||||
| Other equity investment | 9.50%957.22M | 12.34%1.27B | 3.39%1.27B | -8.19%898.42M | -11.83%874.21M | 10.29%1.13B | 30.68%1.23B | -6.56%978.59M | -14.28%991.5M | -18.16%1.03B |
| Other non-current financial assets | -3.88%985.96M | -3.98%995.16M | -11.50%1.02B | -12.09%1.02B | -11.61%1.03B | -11.03%1.04B | -28.93%1.15B | -46.78%1.16B | -51.21%1.16B | -69.96%1.16B |
| Investment real estate | -9.45%126.82B | -8.65%128.85B | 30.50%139.04B | 29.44%137.36B | 26.67%140.06B | 28.08%141.06B | -2.50%106.54B | -0.93%106.12B | 11.25%110.57B | 11.73%110.13B |
| Long-term equity investment | -4.65%106.31B | -7.49%106.91B | -13.19%107.23B | -14.40%109.57B | -13.21%111.5B | -11.48%115.57B | -9.16%123.52B | -7.10%128.01B | 0.14%128.47B | 0.81%130.56B |
| Fixed assets | ---- | ---- | ---- | -2.16%20.41B | ---- | 7.16%20.61B | ---- | 20.81%20.86B | ---- | 17.13%19.23B |
| Constru in process | ---- | ---- | ---- | -5.19%1.01B | ---- | -47.30%1.54B | ---- | -57.32%1.07B | ---- | 57.88%2.92B |
| Productive biological assets | -11.13%209.61M | -14.88%216.12M | -23.84%232.94M | -31.71%238.78M | -9.45%235.86M | 16.33%253.89M | 20.19%305.87M | 51.25%349.67M | -12.29%260.47M | -31.67%218.25M |
| Intangible assets | -10.47%7.27B | -11.22%7.37B | -6.40%7.84B | -2.80%8.04B | -26.22%8.12B | -24.27%8.3B | -22.95%8.38B | -27.40%8.27B | -5.22%11.01B | -5.12%10.96B |
| Goodwill | 2.95%5.7B | 2.95%5.7B | 3.24%5.71B | 3.08%5.71B | 0.01%5.54B | 2.43%5.54B | 2.13%5.53B | 2.33%5.54B | 2.54%5.54B | 0.12%5.41B |
| Long deferred expense | -12.73%6.72B | -9.71%7.19B | -4.71%7.49B | -6.36%7.55B | -6.86%7.7B | -1.35%7.96B | 0.66%7.86B | -1.09%8.06B | -0.63%8.26B | -9.05%8.07B |
| Deferred tax assets | -38.03%27.21B | -37.41%27.58B | 5.23%43.45B | 10.08%43.96B | 10.05%43.91B | 11.90%44.07B | 10.13%41.29B | 4.37%39.93B | 5.85%39.9B | 8.96%39.38B |
| Usufruct assets | -20.76%12.56B | -16.80%13.71B | -16.89%14.47B | -17.73%15.1B | -16.82%15.85B | -15.78%16.49B | -16.07%17.41B | -13.73%18.36B | -12.40%19.06B | -11.76%19.57B |
| Other non current assets | -21.05%3.45B | -32.73%3.49B | -17.26%4.66B | -26.25%4.36B | -26.44%4.37B | -12.52%5.2B | -8.30%5.63B | -9.31%5.91B | -7.09%5.94B | -8.55%5.94B |
| Total non current assets | -11.82%318.07B | -12.34%323.25B | 3.73%353.61B | 3.08%355.22B | 2.24%360.71B | 3.99%368.75B | -4.55%340.9B | -4.05%344.61B | 3.15%352.8B | 3.55%354.59B |
| Total assets | -19.83%997.41B | -20.65%1.02T | -16.25%1.14T | -16.07%1.19T | -15.02%1.24T | -14.53%1.29T | -17.58%1.36T | -15.52%1.42T | -16.02%1.46T | -14.39%1.5T |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 35.28%30.92B | 64.85%26.33B | 170.72%23.49B | 555.88%23.15B | 1,057.08%22.85B | 1,401.85%15.97B | 138.07%8.68B | 43.62%3.53B | -36.29%1.98B | -74.27%1.06B |
| Notes payable and accounts payable | -10.27%121.08B | -18.37%130.63B | -24.71%131.13B | -29.51%136.23B | -32.87%134.94B | -27.81%160.03B | -30.04%174.17B | -25.36%193.26B | -21.75%201.02B | -23.35%221.7B |
| -Notes payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,353.51%7.97M | -68.24%7.97M |
| -Accounts payable | -10.27%121.08B | -18.37%130.63B | -24.71%131.13B | -29.51%136.23B | -32.87%134.94B | -27.81%160.03B | -30.04%174.17B | -25.36%193.26B | -21.75%201.01B | -23.35%221.69B |
| Contract liabilities | -53.00%89.92B | -51.62%93.06B | -47.18%131.91B | -42.93%158B | -35.91%191.29B | -37.67%192.36B | -38.73%249.71B | -35.54%276.87B | -38.72%298.5B | -33.71%308.64B |
| Advance receipts | -4.50%1.84B | -1.62%1.86B | 10.22%1.9B | 1.85%1.84B | 12.92%1.93B | 4.73%1.89B | 7.95%1.72B | 14.21%1.8B | 30.35%1.71B | 43.25%1.81B |
| Salaries payable | 3.17%3.25B | 0.19%3.72B | -33.28%2.44B | -15.19%3.26B | -13.94%3.15B | -13.06%3.72B | -29.27%3.66B | -27.53%3.84B | -27.08%3.66B | -36.80%4.27B |
| Taxs payable | 8.80%30.19B | 5.39%30.49B | 11.17%28.51B | 3.31%26.25B | -1.77%27.75B | -2.82%28.93B | -7.62%25.65B | -12.00%25.41B | -3.57%28.25B | -6.50%29.77B |
| Other payable (including interest and dividends) | -7.01%135.01B | -12.20%133.74B | -8.64%139.95B | -7.62%142.96B | -8.23%145.19B | -5.85%152.32B | -5.40%153.19B | -9.13%154.76B | -9.23%158.2B | -6.97%161.78B |
| -Interest payable | 11,276.28%164.78M | -56.88%49.19M | -82.65%8.34M | --48.63M | -97.04%1.45M | --114.08M | --48.08M | ---- | 0.83%48.86M | ---- |
| -Dividend payable | 10.10%297.83M | 8.85%298.58M | 10.49%304.22M | -27.16%267.93M | 48.82%270.52M | -49.20%274.31M | --275.35M | -95.80%367.81M | -68.90%181.77M | -8.35%539.99M |
| -Other payable | -7.15%134.55B | -12.20%133.39B | -8.65%139.64B | -7.61%142.64B | -8.27%144.92B | -5.77%151.93B | --152.87B | -4.43%154.39B | -9.03%157.97B | -6.97%161.24B |
| Non current liabilities due within one year | 2.84%136.68B | -6.43%136.65B | 14.68%127.89B | 32.09%134.71B | 61.71%132.91B | 124.94%146.05B | 134.82%111.52B | 118.90%101.98B | 37.77%82.19B | 1.57%64.93B |
| Other current liabilities | -53.41%8.21B | -50.92%8.71B | -44.89%12.42B | -41.28%14.64B | -34.26%17.62B | -36.04%17.75B | -37.89%22.54B | -34.86%24.93B | -37.26%26.8B | -31.94%27.75B |
| Total current liabilities | -17.80%557.1B | -21.40%565.2B | -20.13%599.69B | -18.48%641.07B | -15.54%677.71B | -12.50%719.06B | -20.16%750.83B | -19.91%786.44B | -24.29%802.37B | -23.75%821.79B |
| Current liabilities | ||||||||||
| Long term loan | -18.21%149.58B | -12.13%157.19B | -0.61%176.3B | -4.06%178.05B | -3.54%182.89B | -9.55%178.89B | -17.52%177.39B | -13.76%185.58B | -4.77%189.6B | 9.40%197.76B |
| Bonds payable | -55.56%10.19B | -53.16%11.3B | -65.63%11.49B | -62.86%16.24B | -54.34%22.93B | -59.72%24.11B | -44.48%33.44B | -27.68%43.74B | -19.47%50.22B | -13.00%59.87B |
| Estimate liabilities | 65.88%708.02M | -45.52%723.07M | -57.59%393.98M | -55.35%420.55M | -11.02%426.82M | 194.65%1.33B | 111.58%928.87M | 111.24%941.86M | 11.15%479.69M | 9.24%450.4M |
| Deferred tax liabilities | -10.23%4.63B | -12.17%4.7B | 361.46%4.96B | 349.57%5.04B | 337.57%5.15B | 370.23%5.35B | -3.40%1.08B | -0.26%1.12B | 5.03%1.18B | -3.24%1.14B |
| Lease liabilities | -18.62%13.34B | -14.78%14.4B | -14.64%15.25B | -15.65%15.75B | -14.72%16.39B | -14.01%16.89B | -14.90%17.87B | -12.03%18.68B | -11.03%19.22B | -10.97%19.64B |
| Other non current liabilities | 294.70%33.79B | 1,661.29%31.27B | 2,028.62%27.47B | 1,195.57%16.41B | 577.27%8.56B | 40.47%1.78B | 1.74%1.29B | 7.34%1.27B | 11.07%1.26B | 12.42%1.26B |
| Total non current liabilities | -10.20%212.24B | -3.84%219.56B | 1.67%235.87B | -7.72%231.92B | -9.78%236.35B | -18.49%228.34B | -22.44%231.99B | -16.13%251.32B | -8.32%261.96B | 2.10%280.13B |
| Total liabilities | -15.83%769.34B | -17.17%784.76B | -14.98%835.56B | -15.88%872.99B | -14.12%914.06B | -14.02%947.41B | -20.71%982.82B | -19.02%1.04T | -20.90%1.06T | -18.51%1.1T |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%11.93B | 0.00%11.93B | 0.00%11.93B | 0.00%11.93B | 0.00%11.93B | 0.00%11.93B | 0.00%11.93B | 0.00%11.93B | 0.00%11.93B | 2.58%11.93B |
| Capital reserve funds | -3.76%26.95B | 3.40%26.98B | 5.72%26.93B | 6.14%26.98B | 10.55%28B | 4.17%26.1B | 2.64%25.47B | 2.30%25.42B | 6.31%25.33B | 9.55%25.05B |
| Surplus reserve funds | 0.00%126.23B | 0.00%126.23B | 0.00%126.23B | 0.00%126.23B | 0.00%126.23B | 0.00%126.23B | 7.21%126.23B | 7.21%126.23B | 7.21%126.23B | 7.21%126.23B |
| Retained profit | -232.93%-50.37B | -200.64%-44.42B | -78.70%16.12B | -61.57%32.19B | -59.37%37.89B | -52.85%44.14B | -26.93%75.67B | -16.08%83.76B | -6.24%93.25B | -4.49%93.62B |
| Less:Treasury stock | ---- | ---- | ---- | ---- | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B |
| Other composite income | 30.33%-4.2B | 13.90%-3.82B | -40.12%-5.45B | -34.71%-5.89B | -25.22%-6.03B | 6.63%-4.44B | -1.06%-3.89B | -17.76%-4.37B | 14.84%-4.82B | 15.75%-4.75B |
| Shareholders equity without minority interests | -43.81%110.54B | -42.32%116.91B | -24.93%175.76B | -20.79%191.44B | -21.51%196.73B | -19.19%202.67B | -7.43%234.12B | -3.07%241.68B | 1.88%250.63B | 3.07%250.78B |
| Minority interests | -11.80%117.53B | -12.65%118.95B | -10.67%125.27B | -9.53%129.72B | -10.51%133.25B | -10.49%136.19B | -9.07%140.24B | -6.48%143.38B | -1.71%148.9B | -6.26%152.15B |
| Total shareholder equity | -30.88%228.06B | -30.39%235.86B | -19.59%301.03B | -16.59%321.16B | -17.41%329.97B | -15.90%338.85B | -8.05%374.36B | -4.37%385.06B | 0.51%399.53B | -0.67%402.93B |
| Total liabilityies and equity | -19.83%997.41B | -20.65%1.02T | -16.25%1.14T | -16.07%1.19T | -15.02%1.24T | -14.53%1.29T | -17.58%1.36T | -15.52%1.42T | -16.02%1.46T | -14.39%1.5T |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.